AMERICAN JOURNAL OF OPHTHALMOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-07-06 快点发一篇SCI

received by Editor 是什么意思？是还没有送审么？

201 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-10-26 MedSci_007 来自吉林省

会邀请几个审稿人呀？

35 0

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2013-03-09 sunzehong

要版面费吗？？？

305 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-06-19 Charls.Guo

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：流行病学;眼视光
经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。

58 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-08-25 Trna11

请问这个杂志可以共通讯吗

145 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2018-04-06 10cplawhw

我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表:
值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了.

ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了.

311 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-05-09 ms1000001396365998

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：白内障;眼科学
经验分享：无

51 0

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-05-09 ms1000001396365998

无

47 0

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-28 小动量

老牌期刊和新出版期刊是否都要选一些？

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=801471, encodeId=2c0c8014e185, content=received by Editor 是什么意思？是还没有送审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5653022935, createdName=快点发一篇SCI, createdTime=Mon Jul 06 15:54:34 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2165140, encodeId=899521651402a, content=会邀请几个审稿人呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Thu Oct 26 23:48:58 CST 2023, time=2023-10-26, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=494272, encodeId=d3394942e2a8, content=要版面费吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=656f78446, createdName=sunzehong, createdTime=Sat Mar 09 19:00:00 CST 2013, time=2013-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227420, encodeId=c0f9122e4208f, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;眼视光 经验分享：一审一个月，大修，审稿人的统计问题十分严谨，接近提问40个问题；修改了近两个月；返修后由于疫情影响那边好像搁置了两个月，发了催稿信后18天接收。总的来说，审稿人的问题能让本人学到很多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5bbd5545529, createdName=Charls.Guo, createdTime=Sun Jun 19 20:46:36 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812994, encodeId=f097812994c7, content=请问这个杂志可以共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/26/16fe8e130dd541acc2bb8b175c039991.jpg, createdBy=9a1c2360766, createdName=Trna11, createdTime=Tue Aug 25 10:35:04 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554625, encodeId=b61e5546258c, content=我觉得在投稿之前还是要好好斟酌一下文章.不能慌!ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., beContent=ophden 2018-03-28 21:14:00 发表: 值班的间歇.慌慌张张地投了稿.6天后状态变为Exec. Editor Complete.这是个什么鬼状态.最近另一篇临床文章被拒.会不会这个又挂了., objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=649e5792, createdName=10cplawhw, createdTime=Fri Apr 06 00:00:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218003, encodeId=fc32121800346, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：白内障;眼科学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:27:02 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218004, encodeId=b96d12180044c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edb06512899, createdName=ms1000001396365998, createdTime=Mon May 09 08:28:59 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086476, encodeId=e3de10864e69a, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086475, encodeId=7ea910864e590, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 MS68862005

除文章内容和质量外，选刊时还需注意什么？

62 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务